Zura Bio (ZURA) News Today $4.00 0.00 (0.00%) (As of 12/8/2023 ET) Add Compare Share Share Today's Range$3.92▼$4.0350-Day Range$4.00▼$7.0052-Week Range$3.91▼$37.55Volume93,856 shsAverage Volume126,332 shsMarket Capitalization$172.36 millionP/E RatioN/ADividend YieldN/APrice Target$16.60 HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineZura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkokfinance.yahoo.com - December 4 at 10:18 AMShort Interest in Zura Bio Limited (NASDAQ:ZURA) Decreases By 62.9%americanbankingnews.com - November 30 at 3:34 AMZura Bio Appoints Arnout Ploos van Amstel to its Board of Directorsfinance.yahoo.com - November 14 at 10:34 AMZura Bio GAAP EPS of -$0.18msn.com - November 13 at 12:59 PMZura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlightsfinance.yahoo.com - November 13 at 7:58 AMLadenburg Thalmann Initiates Coverage of Zura Bio Ltd - (ZURA) with Buy Recommendationmsn.com - October 11 at 10:15 AMZura Bio Limited (NASDAQ:ZURA) Sees Large Growth in Short Interestmarketbeat.com - September 28 at 6:18 AMZura Bio Enters into Sponsored Research Agreement with Benaroya Research Institutefinance.yahoo.com - September 12 at 9:20 AMZura Bio Ltd. Wtbarrons.com - September 7 at 8:55 PMWe're Hopeful That Zura Bio (NASDAQ:ZURA) Will Use Its Cash Wiselyfinance.yahoo.com - September 7 at 10:53 AMOppenheimer starts Zura Bio at outperform, cites potential of ZB-106msn.com - August 25 at 7:52 PMOppenheimer Initiates Coverage of Zura Bio Ltd - (ZURA) with Outperform Recommendationmsn.com - August 25 at 7:52 PMRaymond James Maintains Zura Bio Ltd - (ZURA) Strong Buy Recommendationmsn.com - August 15 at 4:39 PMWhere Zura Bio Stands With Analystsmarkets.businessinsider.com - August 15 at 4:39 PMZura Bio Reports Second Quarter 2023 Financial Results and Recent Business Highlightsfinance.yahoo.com - August 14 at 9:54 AMShort Interest in Zura Bio Limited (NASDAQ:ZURA) Declines By 40.8%marketbeat.com - July 27 at 2:04 AMZURAW Zura Bio Limited WT EXP 032028seekingalpha.com - July 20 at 8:48 AMZura Bio (NASDAQ:ZURA) Given Buy Rating at Chardan Capitalmarketbeat.com - July 13 at 6:52 AMZura Bio shares are trading lower Wednesday amid possible profit-taking after the stock rallied on Tuesday.benzinga.com - June 23 at 8:32 PMZura Bio to join Russell 2000 and Russell 3000 indexesseekingalpha.com - June 23 at 10:24 AMZura Bio shares are trading higher after the company announced it will join the Russell 2000 and Russell 3000 indexes.benzinga.com - June 23 at 10:24 AMZura Bio a new buy at Guggenheim on immunology, inflammation assetsseekingalpha.com - June 22 at 10:57 PMZura Bio Ltd (94E)investing.com - June 22 at 12:49 AMZura Bio (NASDAQ: ZURA)fool.com - June 21 at 9:49 AMWhat's Going On With Zura Bio Stock Todaymarkets.businessinsider.com - June 21 at 9:49 AMWhy Shares of Zura Bio Climbed Tuesdayfool.com - June 20 at 6:03 PMChardan Capital Comments on Zura Bio Limited's FY2023 Earnings (NASDAQ:ZURA)marketbeat.com - June 19 at 1:35 AMChardan Capital Initiates Coverage On Zura Bio with Buy Rating, Announces Price Target of $14benzinga.com - June 14 at 9:56 AMWhy Is Zura Bio (ZURA) Stock Up 9% Today?investorplace.com - June 6 at 11:15 AMGitLab, Hello Group, Sprinklr, And Other Big Stocks Moving Higher In Tuesday's Pre-Market Sessionmsn.com - June 6 at 8:40 AMZura Shares Jump After $80 Million Private Placement Closesmarketwatch.com - June 6 at 8:40 AMZura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual Antagonistfinance.yahoo.com - June 6 at 8:40 AMZura Bio climbs 7% as director buys stockmsn.com - June 6 at 3:40 AMZura Bio shares are trading higher after Raymond James initiated coverage on the stock with a Strong Buy rating and a $20 price target.benzinga.com - May 24 at 1:07 PMZura Bio soars 37% as Raymond James starts with Strong Buymsn.com - May 24 at 1:07 PMmarketbeat.com - May 24 at 12:15 PMmarketbeat.com - May 24 at 11:48 AMmarketbeat.com - May 24 at 9:34 AMZura Bio Ltd.barrons.com - May 15 at 12:21 AMZura Bio Ltd Ordinary Shares - Class Amorningstar.com - May 11 at 9:00 PMmarketbeat.com - May 11 at 1:51 PMmarketbeat.com - May 11 at 11:53 AMmarketbeat.com - May 11 at 11:25 AMmarketbeat.com - May 11 at 11:03 AMmarketbeat.com - May 11 at 10:59 AMmarketbeat.com - May 11 at 10:48 AMmarketbeat.com - May 11 at 10:15 AMZura Bio Announces $80 Million Financing and the Licensing of Tibulizumab (ZB-106), a Potential First-in-Class anti-IL-17 and anti-BAFF Dual Antagonist for Autoimmune Diseasesfinance.yahoo.com - May 4 at 5:04 PMmarketbeat.com - March 27 at 3:50 PMmarketbeat.com - March 27 at 2:37 PM Get Zura Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter. Email Address ZURA Media Mentions By Week ZURA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZURA News Sentiment▼0.000.51▲Average Medical News Sentiment ZURA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZURA Articles This Week▼12▲ZURA Articles Average Week Get Zura Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SCLX News IVVD News HARP News MESO News LGST News STRO News ERYP News INMB News IPHA News CLLS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:ZURA) was last updated on 12/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zura Bio Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.